MMD2 | Monocyte to macrophage differentiation-associated 2 | Predicted membrane proteins
| | | | | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| | | | | Group enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NMRK2 | Nicotinamide riboside kinase 2 | Enzymes
| | | | | Group enriched |
SLC24A2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TMPRSS11D | Transmembrane protease, serine 11D | Enzymes Predicted membrane proteins
| | | | | Group enriched |
POU3F3 | POU class 3 homeobox 3 | Transcription factors
| | | | | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
SOHLH1 | Spermatogenesis and oogenesis specific basic helix-loop-helix 1 | Disease related genes Transcription factors
| | | | | Group enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KRT16 | Keratin 16 | Disease related genes Plasma proteins
| | | | | Group enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AL158147.2 | HCG2011465; Uncharacterized protein | | | | | | Group enriched |
ISX | Intestine-specific homeobox | Transcription factors
| | | | | Group enriched |
SDR9C7 | Short chain dehydrogenase/reductase family 9C, member 7 | | | | | | Group enriched |
NXPH1 | Neurexophilin 1 | Predicted secreted proteins
| | | | | Group enriched |
SPINK5 | Serine peptidase inhibitor, Kazal type 5 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
DSCR8 | Down syndrome critical region gene 8 | | | | | | Group enriched |
AL138847.1 | CDNA FLJ26506 fis, clone KDN07105; Uncharacterized protein | Predicted secreted proteins
| | | | | Group enriched |
TM4SF20 | Transmembrane 4 L six family member 20 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
SPACA3 | Sperm acrosome associated 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CERS3 | Ceramide synthase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
GBX1 | Gastrulation brain homeobox 1 | Transcription factors
| | | | | Group enriched |
OBP2B | Odorant binding protein 2B | Predicted secreted proteins
| | | | | Group enriched |
POTEH | POTE ankyrin domain family, member H | Predicted membrane proteins
| | | | | Group enriched |
SCN1A | Sodium channel, voltage-gated, type I, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
SPRR2F | Small proline-rich protein 2F | | | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | | | | Group enriched |
SLC17A1 | Solute carrier family 17 (organic anion transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TBX22 | T-box 22 | Disease related genes Transcription factors
| | | | | Group enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SPINK7 | Serine peptidase inhibitor, Kazal type 7 (putative) | Predicted secreted proteins
| | | | | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
C6orf15 | Chromosome 6 open reading frame 15 | Predicted secreted proteins
| | | | | Group enriched |
SPRR1A | Small proline-rich protein 1A | | | | | | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
MAGEA11 | Melanoma antigen family A, 11 | | | | | | Group enriched |
PRSS27 | Protease, serine 27 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
SYNPR | Synaptoporin | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PDILT | Protein disulfide isomerase-like, testis expressed | Predicted secreted proteins
| | | | | Group enriched |
TRIML2 | Tripartite motif family-like 2 | | | | | | Group enriched |
GOLGA6B | Golgin A6 family, member B | | | | | | Group enriched |
MRAP | Melanocortin 2 receptor accessory protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
RPTN | Repetin | | | | | | Group enriched |
SERPINB7 | Serpin peptidase inhibitor, clade B (ovalbumin), member 7 | Disease related genes
| | | | | Group enriched |